Variables n/%
Age (mean±SD) 64±9.4
Gender (Male/female) 16/2
Histopathology SCLC2 NSCLC3 Adenocarcinoma Squamous cell carcinoma 5 (27.8%) 13 (72.2%) 5 (27.8%) 8 (44.4%)
TNM Stage Stage I-II Stage III Stage IV 2 (11.1%) 6 (33.3%) 10 (55.6%)
Therapy Chemotherapy Palliative radiotherapy Immunothetapy Best supportive care Chemo-radiotherapy Treatment completed 9 (50%) 1 (5.6%) 1 (5.6%) 3 (16.7%) 2 (11.1%) 2 (11.1%)
Symptom Fever Shortness of breath Sputum purulence Cough Myalgia 10 (55.6%) 14 (77.8%) 5 (31.2%) 5 (31.2%) 3 (18.7%)
Pathology on X-ray 14 (77.8%)
Hypoxia 11 (61.1.%)
Lymphopenia 12 (75%)
Elevated lactate dehydrogenase 12 (75%)
Tomography findings Consolidation Ground glass opacities Thoracic mass/Lymphadenopathy Pleural efussion 8 (44.4%) 8 (44.4%) 3 (16.7%) 5 (27.8%)